investigational protease inhibitor, Aptivus (tipranavir)

August 2005

You'll hear about an investigational protease inhibitor, Aptivus (tipranavir).

It's the first NON-peptidic protease inhibitor (PI).

PIs have trouble adapting their shape when HIV protease enzymes mutate. Aptivus is more "flexible"...hopefully making it harder for resistance to develop.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

new recommendations from its expert panel on selective COX-2 NSAIDs
Diabetes pioglitazone (Actos) improves lipids better than rosiglitazone (Avandia)
Diabetes The many new insulins have people confused about which one to use
Infectious Diseases appropriate use of Dukoral vaccine for travellers
Infectious Diseases investigational protease inhibitor, Aptivus (tipranavir)
Dermatology Drug absorption from a patch can be dangerously increased by heat
Dermatology sunscreen ingredient called mexoryl is drawing attention to the importance of UVA protection
Cardiology isosorbide dinitrate and hydralazine for heart failure in blacks
Women s Health alternatives to prescription meds for premenstrual syndrome (PMS)
Lyrica (pregabalin) for some types of neuropathic pain
People are hearing about potential safety concerns with Concerta
Psychiatry what's effective for post-traumatic stress disorder (PTSD)
Anticoagulants Pharmacist anticoagulation services improve care and reduce costs
Men s Health different ways of administering Viagra to speed up absorption

investigational protease inhibitor, Aptivus (tipranavir)

Practical advice for a better career, with unlimited access to CE

Table of Contents